Clinical Trials Directory

Trials / Completed

CompletedNCT00883597

Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation

Sidestream Dark-Field Imaging of the Intestinal Microcirculation in Clinical Sepsis: The Impact of Activated Protein C Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Nova Scotia Health Authority · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Sepsis is the most frequent cause of death in critically ill patients in non-coronary care Intensive Care Units in the developed world. Microcirculatory disturbances are central to the development of the disorder, leading to organ dysfunction, multi-organ failure and fatal outcome. In particular the intestinal microcirculation is impaired early in the course of the disease. This may result in a breakdown of the gut barrier function with translocation of bacteria and their toxins into the systemic circulation, thus sustaining a "gut derived" septic state. Therefore, the impaired intestinal microcirculation has been suggested to act as the "motor of multiple organ failure" in sepsis. The aim of the project is to evaluate a new diagnostic tool and the impact of Activated Protein C administration on the intestinal microcirculation in patients with severe sepsis and compare the findings with septic patients who are not candidates for APC therapy and healthy patients post bowel surgery using an innovative diagnostic tool (side stream dark-field imaging, SDF).

Conditions

Timeline

Start date
2011-11-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2009-04-17
Last updated
2024-08-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00883597. Inclusion in this directory is not an endorsement.